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Case Report
PROSTATE ADENOCARCINOMA WITH UNILATERAL TESTICULAR METASTASIS: 
TWO CASES WITH DIFFERENT PRESENTATIONS
ABSTRACT
Background: Most patients with prostate cancer present with advanced disease in sub-Saharan Africa. However, metastasis 
to the testis is rare. 
Findings: This report details the incidental detection of isolated unilateral metastasis to the testis and epididymis from the 
prostate on histopathologic analysis of the orchidectomy specimen in a 77-year-old man (case 1) and the finding of palpable 
unilateral testicular secondary from aggressive metastatic prostate cancer in a relatively younger man (47 years old) during 
clinical evaluation (case 2). 
Conclusion: The presentation of testicular metastasis from prostate cancer varies with the patient. A high index of suspicion 
in the phases of evaluation of these patients is required in order to prevent missed diagnosis.
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rostate cancer is the most common solid tumour in 
adults. It tends to be relatively more aggressive in 
black populations. In sub-Saharan Africa, where P
prostate cancer screening is minimal, most patients still 
present with advanced stages of the disease. Testicular 
metastasis from a prostate primary is rare despite their 
proximity. It was first reported by Semans about 100 years 
ago. It is reported by some studies to occur in 0.5-4.0% of all 
prostate cancer cases and is usually incidentally detected 
following orchidectomy for prostate cancer treatment.
CASE REPORTS
We review the presentation of 2 cases of advanced prostate 
cancer with unilateral testicular metastasis.
Case Report 1
A 77-year-old man who presented to the urology clinic of 
our hospital with obstructive and irritative lower urinary 
tract symptoms, weight loss and hematuria. He had no 
other symptoms. Digital Rectal Examination revealed an 
asymmetrically enlarged prostate with multiple hard 
nodules. Prostate-Specific Antigen (PSA) was 92 ng/ml. 
Trans-rectal ultrasound scan showed a prostate with 
distorted parenchymal echotexture, multiple hypoechoic 
nodules in the peripheral zone and a breached capsule. A 
tru-cut biopsy was done, and the histology revealed 
prostate adenocarcinoma, Gleason score 7 (3+4). The 
metastatic survey revealed no evidence of distant spread.
A diagnosis of locally advanced prostate cancer with 
clinical stage of T N M  was made. The patient was 4 0 0
counselled for androgen deprivation therapy and opted 
for orchidectomy. The histological analysis of the testicular 
tissue, removed at orchidectomy, revealed metastatic 
adenocarcinoma involving the left testicular tissue and 
epididymis (Figure 1). Post-hormonal ablation 
testosterone level was 0.3ng/ml. He is currently 15 months 
on follow up and has been asymptomatic.
Case Report 2
A 47-year-old man referred from a secondary health care 
facility with transfusion-dependent anaemia of 4 months 
duration. He had been transfused with a total of 10 units of 
blood. He also had a history of significant weight loss, 
anorexia and generalized body weakness as well as low 
back pain and lower limb weakness. No lower urinary tract 
symptoms or haematuria. Examination revealed a 
cachectic, pale-looking patient with left-sided facial nerve 
palsy (upper motor neuron type), nodular right testis and 
an enlarged prostate with a hard, nodular surface on both 
lobes and obliterated median groove. Retroviral screening 
and Mantoux test were negative. The metastatic survey 
showed widespread abdominal masses in the region of the 
pancreatic body and adrenal gland, multiple osteolytic 
lesions in the lumbar vertebrae and pelvic bones and right-
sided pleural effusion. Serum Prostate Specific Antigen 
w a s  > 1 0 0  n g / m l .  P r o s t a t e  b i o p s y  r e v e a l e d  
adenocarcinoma, Gleason score 8 (5 + 3).
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A diagnosis of metastatic prostate cancer (T N M ) was 4 1 1c
made. Due to his poor performance status, the patient was 
resuscitated, counselled and placed on androgen 
deprivation therapy (depot injection of 3.6mg Goserelin) as 
first-line therapy. He later consented for bilateral 
orchidectomy where histology of the right testis confirmed 
metastatic adenocarcinoma (Figure 2).
Prostate-Specific Antigen 6 months after hormonal 
ablation was still > 100 ng/ml and he is presently on 
combined androgen blockade in our follow-up clinic.
DISCUSSION
Metastasis of solid tumours to the testis are generally rare; 
however, the prostate represents its most common 
primary site. Oranusi et al. noted that two-third of the 
secondary metastasis to the testis were from the prostate, 
while Haupt et al. published that it represents 35% of all 
secondary testicular tumours. 
The patients diagnosed with this rare metastasis tend to be 
older than those with primary testicular tumours. Most of 
the reports of patients with testicular metastasis of prostate 
–cancer were in their seventh decade of life.  Others have 
reported patients in their eight-decade in line with the age 
of the patient in case report 1. An old patient with an 
abnormal testis could suggest metastasis from a primary 
tumour. However, the occurrence of testicular metastasis 
in a 47-year-old male in the second case is similar to the 
observation of Kyei et al. in Accra. This suggests that these 
secondaries could occur in young men with aggressive 
prostate cancer.
Prostatic urethral involvement increases the likelihood of 
testicular metastasis; this might have occurred in the first 
case who presented with LUTS. This is similar to the report 
by Zhang et al. in which the patient presented with the 
same symptom. Spread to the testis could occur by direct 
invasion, lymphatic spread, retrograde venous 
involvement and arterial embolism. In addition, the 
pattern of metastatic infiltration could be intertubular, 
intratubular with/out vascular and lymphatic invasion. In 
case report 1, a lesion was found in the epididymis 
suggesting a probable extension through the vas 
(endocanalicular route). This is in contrast to the report by 
Chapagain et al. in which there was no lesion in the 
epididymis. The widespread metastatic lesion in the 
second case report could mean that the testicular spread 
occurred via the haematogenous route. 
Risk factors for testicular metastasis include high PSA 
levels and high Gleason's score. Unlike the first case, the 
aggressiveness of cancer in the second case is highlighted 
by its higher primary Gleason's grade and higher Gleason's 
score. Most of the PSA in previous studies were greater 
than 100 ng/ml, similar to the finding in the second report. 
Others have however documented a PSA of less than 100 
ng/ml which is similar to the reported PSA found in our 
first case.
Patients with testicular metastasis from the prostate tend to 
have widespread metastases at other sites as seen in the 
second case. Korkes et al. noted that all their patients had 
bone and lung metastasis. However, the first case did not 
have any evidence of distant cancer spread within the 
limits of the investigations done.
Testicular metastasis from a prostate primary is usually 
incidentally detected during autopsies or following 
bilateral orchiectomy and could present as a synchronous 
or metachronous lesion. In the first case, the clinically silent 
unilateral testicular metastasis was incidentally detected at 
orchidectomy done 3 months after the diagnosis of the 
primary tumour while the metastasis in the second case 
presented as a clinically palpable nodule felt on the 
examination of the testes. 
Reported cases of these testicular secondaries are usually 
unilateral but may be bilateral in a lesser proportion of 
cases. The metastasis to the testis in both cases reported in 
this study were unilateral. This is in consonance with the 
work of Korkes et al. in which 2 of the 3 patients reported 
had unilateral metastasis. However, Kim et al. reported 
bilateral involvement of the testis. Others have also 
reported testicular metastasis presenting as a painless 
palpable testicular mass (13-23%) which creates diagnostic 
difficulty differentiating it from primary testicular cancer.
In testicular metastasis from prostate cancer, it is possible 
that orchidectomy plays a more important role in 
treatment because Su et al. noted that it provided a means 
for the extirpation of the prostate cancer cells including 
isolated ones at this immune-privileged site. However, the 
persistence of PSA following this treatment in the second 
case could be related to the poor response of the metastatic 
tumour cells at the other sites to first-line androgen 
deprivation therapy. As such, the patient was placed on 
combined androgen blockade. 
The significance of testicular metastasis in the prognosis of 
prostate carcinoma is uncertain in view of its rarity in 
advanced disease. Survival after diagnosis is usually less 
than 1 year. Korkes et al. reported a post-orchidectomy 
median survival of 5.3 months. In the first case, the patient 
has lived 15 months post-orchidectomy without 
symptoms, while the patient in the second case has lived 
for 6 months post-orchidectomy.
Other options have also been used in the treatment of 
metastatic prostate cancer. There is a need to compare 
oncologic outcomes of orchidectomy with the use of LHRH 
analogues and systemic chemotherapy in patients having 
prostate cancer with testicular metastasis. 
In conclusion, the presentation of testicular metastasis 
from prostate cancer varies with the patient. A high index 
of suspicion in the phases of evaluation of these patients is 
required in order to prevent missed diagnosis.
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Figure 1: Metastatic adenocarcinoma to the testis and 
epididymis (HE Stain, X100)
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Figure 2: Metastatic adenocarcinoma to the testis (HE Stain, X100)
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